Ford K et al. 2022. Clinical Use of Peptide-Based Formula (Peptamen Junior®, Nestle) in the Paediatric Population
This retrospective observational audit describes the characteristics of the paediatric patients who have been prescribed a hydrolysed whey protein, medium chain triglycerides (MCT) based formula, Peptamen Junior® and the nutritional outcomes. This study demonstrates that semi elemental formula Peptamen Junior® appears to be well tolerated in paediatric patients with a variety of medical conditions that have complex pathologies and may have wider scope of use in a more diverse group of medical conditions than currently indicated.